Virtual West Oncology Conference
ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Relapse After CAR-T or ASCT, CAR-T & Bispecific Antibodies for Indolent Lymphomas
By
Virtual West Oncology Conference
FEATURING
Neha Mehta-Shah
By
Virtual West Oncology Conference
FEATURING
Neha Mehta-Shah
Login to view comments.
Click here to Login